Symbol:
Lama2
Name:
laminin subunit alpha 2
RGD ID:
1308889
Description:
Predicted to be an extracellular matrix structural constituent. Involved in Schwann cell differentiation. Located in basement membrane and dendritic spine. Biomarker of renovascular hypertension. Human ortholog(s) of this gene implicated in autosomal recessive limb-girdle muscular dystrophy; congenital merosin-deficient muscular dystrophy 1A; muscular dystrophy; and myopia. Orthologous to human LAMA2 (laminin subunit alpha 2); PARTICIPATES IN arrhythmogenic right ventricular cardiomyopathy pathway; cell-extracellular matrix signaling pathway; dilated cardiomyopathy pathway; INTERACTS WITH 17alpha-ethynylestradiol; 2,3,7,8-tetrachlorodibenzodioxine; amphetamine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
laminin subunit alpha-2; laminin, alpha 2; LOC309368
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
LAMA2 (laminin subunit alpha 2) HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, Treefam
Mus musculus (house mouse):
Lama2 (laminin, alpha 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Lama2 (laminin subunit alpha 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
LAMA2 (laminin subunit alpha 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
LAMA2 (laminin subunit alpha 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Lama2 (laminin subunit alpha 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
LAMA2 (laminin subunit alpha 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
LAMA2 (laminin subunit alpha 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Lama2 (laminin subunit alpha 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
LAMA2 (laminin subunit alpha 2)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Lama2 (laminin, alpha 2)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
lama2 (laminin, alpha 2)
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PhylomeDB)
Caenorhabditis elegans (roundworm):
lam-3
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Drosophila melanogaster (fruit fly):
wb
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
lama2
Alliance
DIOPT (Ensembl Compara|OrthoFinder)
Allele / Splice:
Lama2Tn(sb-T2/Bart3)2.2013Mcwi
Genetic Models:
F344-Lama2Tn(sb-T2/Bart3)2.2013Mcwi
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 19,492,126 - 20,140,056 (+) NCBI GRCr8 mRatBN7.2 1 17,672,675 - 18,320,641 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 17,672,536 - 18,320,530 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 1 18,491,264 - 19,143,486 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 18,491,384 - 19,143,269 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 20,002,787 - 20,647,256 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 18,203,466 - 18,885,462 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 18,324,930 - 18,885,310 (+) NCBI Celera 1 16,078,601 - 16,724,118 (+) NCBI Celera Cytogenetic Map 1 p12 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Lama2 Rat 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of LAMA2 mRNA CTD PMID:17557909 Lama2 Rat 17beta-estradiol increases expression ISO Lama2 (Mus musculus) 6480464 Estradiol results in increased expression of LAMA2 mRNA CTD PMID:19484750 Lama2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Lama2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of LAMA2 mRNA CTD PMID:17586704 Lama2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LAMA2 mRNA CTD PMID:34747641 Lama2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LAMA2 mRNA CTD PMID:32109520 Lama2 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO LAMA2 (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 Lama2 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Lama2 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 Lama2 Rat 4,4'-sulfonyldiphenol increases expression ISO Lama2 (Mus musculus) 6480464 bisphenol S results in increased expression of LAMA2 mRNA CTD PMID:30951980 Lama2 Rat 4,4'-sulfonyldiphenol decreases expression ISO LAMA2 (Homo sapiens) 6480464 bisphenol S results in decreased expression of LAMA2 mRNA CTD PMID:30616060 Lama2 Rat 4-hydroxyphenyl retinamide decreases expression ISO Lama2 (Mus musculus) 6480464 Fenretinide results in decreased expression of LAMA2 mRNA CTD PMID:28973697 Lama2 Rat 9-cis-retinoic acid decreases expression ISO LAMA2 (Homo sapiens) 6480464 Alitretinoin results in decreased expression of LAMA2 mRNA CTD PMID:15982314 Lama2 Rat aflatoxin B1 increases methylation ISO LAMA2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of LAMA2 intron CTD PMID:30157460 Lama2 Rat all-trans-4-oxoretinoic acid decreases expression ISO LAMA2 (Homo sapiens) 6480464 4-oxoretinoic acid results in decreased expression of LAMA2 mRNA CTD PMID:15982314 Lama2 Rat all-trans-retinoic acid decreases expression ISO LAMA2 (Homo sapiens) 6480464 Tretinoin metabolite results in decreased expression of LAMA2 mRNA and Tretinoin results in decreased expression of LAMA2 mRNA CTD PMID:15982314 Lama2 Rat all-trans-retinoic acid decreases expression ISO Lama2 (Mus musculus) 6480464 Tretinoin results in decreased expression of LAMA2 mRNA CTD PMID:16604517 Lama2 Rat amiodarone increases expression ISO Lama2 (Mus musculus) 6480464 Amiodarone results in increased expression of LAMA2 mRNA CTD PMID:24489787 Lama2 Rat amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of LAMA2 mRNA CTD PMID:30779732 Lama2 Rat arsenite(3-) increases methylation ISO LAMA2 (Homo sapiens) 6480464 arsenite results in increased methylation of LAMA2 promoter CTD PMID:23974009 Lama2 Rat atrazine multiple interactions ISO LAMA2 (Homo sapiens) 6480464 [Atrazine co-treated with Arsenates] results in increased expression of LAMA2 mRNA CTD PMID:18585445 Lama2 Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of LAMA2 gene CTD PMID:28931070 and PMID:35440735 Lama2 Rat benzo[a]pyrene affects methylation ISO LAMA2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of LAMA2 exon more ... CTD PMID:27901495 and PMID:30157460 Lama2 Rat benzo[a]pyrene increases methylation ISO LAMA2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of LAMA2 5' UTR CTD PMID:27901495 Lama2 Rat Benzo[k]fluoranthene increases expression ISO Lama2 (Mus musculus) 6480464 benzo(k)fluoranthene results in increased expression of LAMA2 mRNA CTD PMID:26377693 Lama2 Rat bis(2-chloroethyl) sulfide decreases expression ISO Lama2 (Mus musculus) 6480464 Mustard Gas results in decreased expression of LAMA2 mRNA CTD PMID:15674843 Lama2 Rat bisphenol A decreases expression ISO Lama2 (Mus musculus) 6480464 bisphenol A results in decreased expression of LAMA2 mRNA CTD PMID:26063408 and PMID:32156529 Lama2 Rat bisphenol A increases expression ISO Lama2 (Mus musculus) 6480464 bisphenol A results in increased expression of LAMA2 mRNA CTD PMID:30951980 and PMID:33221593 Lama2 Rat bisphenol A increases expression ISO LAMA2 (Homo sapiens) 6480464 bisphenol A results in increased expression of LAMA2 mRNA CTD PMID:29275510 Lama2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LAMA2 mRNA CTD PMID:30816183 more ... Lama2 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of LAMA2 mRNA CTD PMID:25181051 Lama2 Rat bisphenol F increases expression ISO Lama2 (Mus musculus) 6480464 bisphenol F results in increased expression of LAMA2 mRNA CTD PMID:30951980 Lama2 Rat calcitriol decreases expression ISO LAMA2 (Homo sapiens) 6480464 Calcitriol results in decreased expression of LAMA2 mRNA CTD PMID:26485663 Lama2 Rat cantharidin decreases expression ISO Lama2 (Mus musculus) 6480464 Cantharidin results in decreased expression of LAMA2 mRNA CTD PMID:36907384 Lama2 Rat captan decreases expression ISO Lama2 (Mus musculus) 6480464 Captan results in decreased expression of LAMA2 mRNA CTD PMID:31558096 Lama2 Rat carbon nanotube decreases expression ISO Lama2 (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of LAMA2 mRNA CTD PMID:25554681 Lama2 Rat cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of LAMA2 mRNA CTD PMID:18500788 Lama2 Rat chlorpyrifos increases expression ISO Lama2 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of LAMA2 mRNA CTD PMID:37019170 Lama2 Rat choline multiple interactions ISO Lama2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LAMA2 mRNA CTD PMID:20938992 Lama2 Rat chromium(6+) increases expression ISO LAMA2 (Homo sapiens) 6480464 chromium hexavalent ion results in increased expression of LAMA2 protein CTD PMID:28596144 Lama2 Rat cisplatin increases response to substance ISO LAMA2 (Homo sapiens) 6480464 LAMA2 mRNA results in increased susceptibility to Cisplatin CTD PMID:25199881 Lama2 Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of LAMA2 mRNA CTD PMID:26577399 Lama2 Rat dibenz[a,h]anthracene increases expression ISO Lama2 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 Lama2 Rat dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of LAMA2 mRNA CTD PMID:21266533 Lama2 Rat diquat decreases expression ISO Lama2 (Mus musculus) 6480464 Diquat results in decreased expression of LAMA2 mRNA CTD PMID:36851058 Lama2 Rat disodium selenite multiple interactions ISO Lama2 (Mus musculus) 6480464 [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of LAMA2 mRNA CTD PMID:23274088 Lama2 Rat disodium selenite decreases expression ISO Lama2 (Mus musculus) 6480464 Sodium Selenite results in decreased expression of LAMA2 mRNA CTD PMID:23274088 Lama2 Rat diuron decreases expression EXP 6480464 Diuron results in decreased expression of LAMA2 mRNA CTD PMID:25152437 Lama2 Rat dorsomorphin multiple interactions ISO LAMA2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Lama2 Rat doxorubicin increases response to substance ISO LAMA2 (Homo sapiens) 6480464 LAMA2 mRNA results in increased susceptibility to Doxorubicin CTD PMID:25199881 Lama2 Rat doxorubicin increases expression ISO LAMA2 (Homo sapiens) 6480464 Doxorubicin results in increased expression of LAMA2 mRNA CTD PMID:37062353 Lama2 Rat doxorubicin decreases expression ISO LAMA2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of LAMA2 mRNA CTD PMID:29803840 Lama2 Rat epoxiconazole increases expression ISO Lama2 (Mus musculus) 6480464 epoxiconazole results in increased expression of LAMA2 mRNA CTD PMID:35436446 Lama2 Rat ethanol increases expression ISO Lama2 (Mus musculus) 6480464 Ethanol results in increased expression of LAMA2 mRNA CTD PMID:30319688 Lama2 Rat folic acid multiple interactions ISO Lama2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LAMA2 mRNA CTD PMID:20938992 Lama2 Rat fonofos increases methylation ISO LAMA2 (Homo sapiens) 6480464 Fonofos results in increased methylation of LAMA2 promoter CTD PMID:22847954 Lama2 Rat inulin multiple interactions ISO Lama2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LAMA2 mRNA CTD PMID:36331819 Lama2 Rat isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of LAMA2 CTD PMID:18808529 Lama2 Rat isotretinoin decreases expression ISO LAMA2 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of LAMA2 mRNA CTD PMID:15982314 Lama2 Rat isotretinoin increases expression ISO LAMA2 (Homo sapiens) 6480464 Isotretinoin results in increased expression of LAMA2 mRNA CTD PMID:20436886 Lama2 Rat L-methionine multiple interactions ISO Lama2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LAMA2 mRNA CTD PMID:20938992 Lama2 Rat lead diacetate increases expression ISO Lama2 (Mus musculus) 6480464 lead acetate results in increased expression of LAMA2 mRNA CTD PMID:22609695 Lama2 Rat lipopolysaccharide multiple interactions ISO LAMA2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LAMA2 mRNA CTD PMID:35811015 Lama2 Rat methotrexate increases response to substance ISO LAMA2 (Homo sapiens) 6480464 LAMA2 mRNA results in increased susceptibility to Methotrexate CTD PMID:25199881 Lama2 Rat mifepristone decreases expression ISO LAMA2 (Homo sapiens) 6480464 Mifepristone results in decreased expression of LAMA2 mRNA CTD PMID:17584828 Lama2 Rat mitoxantrone affects response to substance ISO LAMA2 (Homo sapiens) 6480464 LAMA2 mRNA affects the susceptibility to Mitoxantrone CTD PMID:16044152 Lama2 Rat N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of LAMA2 gene CTD PMID:33148267 Lama2 Rat N-ethyl-N-nitrosourea increases mutagenesis ISO Lama2 (Mus musculus) 6480464 Ethylnitrosourea results in increased mutagenesis of LAMA2 gene CTD PMID:16724327 Lama2 Rat nickel atom decreases expression ISO LAMA2 (Homo sapiens) 6480464 Nickel results in decreased expression of LAMA2 mRNA CTD PMID:25583101 Lama2 Rat paclitaxel increases response to substance ISO LAMA2 (Homo sapiens) 6480464 LAMA2 mRNA results in increased susceptibility to Paclitaxel CTD PMID:25199881 Lama2 Rat panobinostat increases expression ISO LAMA2 (Homo sapiens) 6480464 panobinostat results in increased expression of LAMA2 mRNA CTD PMID:26272509 Lama2 Rat panobinostat multiple interactions ISO LAMA2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMA2 mRNA CTD PMID:27188386 Lama2 Rat parathion increases methylation ISO LAMA2 (Homo sapiens) 6480464 Parathion results in increased methylation of LAMA2 promoter CTD PMID:22847954 Lama2 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Lama2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LAMA2 mRNA CTD PMID:36331819 Lama2 Rat permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of LAMA2 gene CTD PMID:33148267 Lama2 Rat phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of LAMA2 mRNA CTD PMID:20345932 Lama2 Rat pioglitazone multiple interactions ISO Lama2 (Mus musculus) 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of LAMA2 mRNA CTD PMID:27935865 Lama2 Rat potassium dichromate decreases expression ISO Lama2 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of LAMA2 mRNA CTD PMID:23608068 Lama2 Rat progesterone increases expression ISO Lama2 (Mus musculus) 6480464 Progesterone results in increased expression of LAMA2 mRNA CTD PMID:22238285 Lama2 Rat propanal increases expression ISO LAMA2 (Homo sapiens) 6480464 propionaldehyde results in increased expression of LAMA2 mRNA CTD PMID:26079696 Lama2 Rat Ptaquiloside multiple interactions ISO Lama2 (Mus musculus) 6480464 [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of LAMA2 mRNA CTD PMID:23274088 Lama2 Rat Ptaquiloside decreases expression ISO Lama2 (Mus musculus) 6480464 ptaquiloside results in decreased expression of LAMA2 mRNA CTD PMID:23274088 Lama2 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO LAMA2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LAMA2 mRNA CTD PMID:35811015 Lama2 Rat SB 431542 multiple interactions ISO LAMA2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Lama2 Rat silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of LAMA2 mRNA CTD PMID:22431001 Lama2 Rat silicon dioxide decreases expression ISO LAMA2 (Homo sapiens) 6480464 Silicon Dioxide results in decreased expression of LAMA2 mRNA CTD PMID:25351596 Lama2 Rat sodium arsenate increases expression ISO Lama2 (Mus musculus) 6480464 sodium arsenate results in increased expression of LAMA2 mRNA CTD PMID:21795629 Lama2 Rat sodium arsenite affects methylation ISO LAMA2 (Homo sapiens) 6480464 sodium arsenite affects the methylation of LAMA2 gene CTD PMID:28589171 Lama2 Rat sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of LAMA2 mRNA CTD PMID:22110744 Lama2 Rat sodium fluoride decreases expression ISO Lama2 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of LAMA2 protein CTD PMID:28918527 Lama2 Rat sotorasib multiple interactions ISO LAMA2 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LAMA2 mRNA CTD PMID:36139627 Lama2 Rat terbufos increases methylation ISO LAMA2 (Homo sapiens) 6480464 terbufos results in increased methylation of LAMA2 promoter CTD PMID:22847954 Lama2 Rat tetrachloromethane affects expression ISO Lama2 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of LAMA2 mRNA CTD PMID:17484886 Lama2 Rat topotecan increases response to substance ISO LAMA2 (Homo sapiens) 6480464 LAMA2 mRNA results in increased susceptibility to Topotecan CTD PMID:25199881 Lama2 Rat trametinib multiple interactions ISO LAMA2 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LAMA2 mRNA CTD PMID:36139627 Lama2 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of LAMA2 mRNA CTD PMID:33387578 Lama2 Rat trichostatin A increases expression ISO LAMA2 (Homo sapiens) 6480464 trichostatin A results in increased expression of LAMA2 mRNA CTD PMID:24935251 Lama2 Rat triclosan decreases expression ISO LAMA2 (Homo sapiens) 6480464 Triclosan results in decreased expression of LAMA2 mRNA CTD PMID:30510588 Lama2 Rat triphenyl phosphate affects expression ISO LAMA2 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of LAMA2 mRNA CTD PMID:37042841 Lama2 Rat valproic acid affects expression ISO LAMA2 (Homo sapiens) 6480464 Valproic Acid affects the expression of LAMA2 mRNA CTD PMID:25979313 Lama2 Rat valproic acid increases expression ISO LAMA2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of LAMA2 mRNA CTD PMID:23179753 more ... Lama2 Rat valproic acid multiple interactions ISO LAMA2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMA2 mRNA CTD PMID:27188386 Lama2 Rat vincristine increases response to substance ISO LAMA2 (Homo sapiens) 6480464 LAMA2 mRNA results in increased susceptibility to Vincristine CTD PMID:25199881
Imported Annotations - KEGG (archival)
17alpha-ethynylestradiol (EXP) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) 9-cis-retinoic acid (ISO) aflatoxin B1 (ISO) all-trans-4-oxoretinoic acid (ISO) all-trans-retinoic acid (ISO) amiodarone (ISO) amphetamine (EXP) arsenite(3-) (ISO) atrazine (EXP,ISO) benzo[a]pyrene (ISO) Benzo[k]fluoranthene (ISO) bis(2-chloroethyl) sulfide (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) calcitriol (ISO) cantharidin (ISO) captan (ISO) carbon nanotube (ISO) cefaloridine (EXP) chlorpyrifos (ISO) choline (ISO) chromium(6+) (ISO) cisplatin (ISO) Cuprizon (EXP) dibenz[a,h]anthracene (ISO) dibutyl phthalate (EXP) diquat (ISO) disodium selenite (ISO) diuron (EXP) dorsomorphin (ISO) doxorubicin (ISO) epoxiconazole (ISO) ethanol (ISO) folic acid (ISO) fonofos (ISO) inulin (ISO) isoprenaline (EXP) isotretinoin (ISO) L-methionine (ISO) lead diacetate (ISO) lipopolysaccharide (ISO) methotrexate (ISO) mifepristone (ISO) mitoxantrone (ISO) N,N-diethyl-m-toluamide (EXP) N-ethyl-N-nitrosourea (ISO) nickel atom (ISO) paclitaxel (ISO) panobinostat (ISO) parathion (ISO) perfluorooctane-1-sulfonic acid (ISO) permethrin (EXP) phenytoin (EXP) pioglitazone (ISO) potassium dichromate (ISO) progesterone (ISO) propanal (ISO) Ptaquiloside (ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) SB 431542 (ISO) silicon dioxide (EXP,ISO) sodium arsenate (ISO) sodium arsenite (ISO) sodium dichromate (EXP) sodium fluoride (ISO) sotorasib (ISO) terbufos (ISO) tetrachloromethane (ISO) topotecan (ISO) trametinib (ISO) trichloroethene (EXP) trichostatin A (ISO) triclosan (ISO) triphenyl phosphate (ISO) valproic acid (ISO) vincristine (ISO)
1.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
2.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
3.
Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy.
Helbling-Leclerc A, etal., Nat Genet. 1995 Oct;11(2):216-8.
4.
Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism.
Kemaladewi DU, etal., Nat Med. 2017 Aug;23(8):984-989. doi: 10.1038/nm.4367. Epub 2017 Jul 17.
5.
Expression of laminin-2 by normal and neoplastic rat C cells during the development of medullary thyroid carcinoma.
Lekmine F, etal., Virchows Arch. 1999 Apr;434(4):325-32.
6.
Expression of dystroglycan complex in satellite cells of dorsal root ganglia.
Masaki T, etal., Acta Neuropathol (Berl). 2001 Feb;101(2):174-8.
7.
Expression of dystroglycan and the laminin-alpha 2 chain in the rat peripheral nerve during development.
Masaki T, etal., Exp Neurol. 2002 Mar;174(1):109-17.
8.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
9.
Expression of laminin alpha2 chain during normal and pathological growth of myocardium in rat and human.
Oliviero P, etal., Cardiovasc Res. 2000 May;46(2):346-55.
10.
OMIM Disease Annotation Pipeline
OMIM Disease Annotation Pipeline
11.
KEGG Annotation Import Pipeline
Pipeline to import KEGG annotations from KEGG into RGD
12.
GOA pipeline
RGD automated data pipeline
13.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
14.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
15.
Comprehensive gene review and curation
RGD comprehensive gene curation
16.
Laminin-alpha2 chain-like antigens in CNS dendritic spines.
Tian M, etal., Brain Res. 1997 Aug 1;764(1-2):28-38.
17.
When do myopia genes have their effect? Comparison of genetic risks between children and adults.
Tideman JW, etal., Genet Epidemiol. 2016 Dec;40(8):756-766. doi: 10.1002/gepi.21999. Epub 2016 Sep 9.
Lama2 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 19,492,126 - 20,140,056 (+) NCBI GRCr8 mRatBN7.2 1 17,672,675 - 18,320,641 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 17,672,536 - 18,320,530 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 1 18,491,264 - 19,143,486 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 18,491,384 - 19,143,269 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 20,002,787 - 20,647,256 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 18,203,466 - 18,885,462 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 18,324,930 - 18,885,310 (+) NCBI Celera 1 16,078,601 - 16,724,118 (+) NCBI Celera Cytogenetic Map 1 p12 NCBI
LAMA2 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 6 128,883,138 - 129,516,566 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 6 128,883,138 - 129,516,566 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 6 129,204,283 - 129,837,711 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 6 129,245,979 - 129,879,404 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 6 129,246,034 - 129,879,401 NCBI Celera 6 129,950,556 - 130,583,793 (+) NCBI Celera Cytogenetic Map 6 q22.33 NCBI HuRef 6 126,785,527 - 127,418,362 (+) NCBI HuRef CHM1_1 6 129,468,357 - 130,101,369 (+) NCBI CHM1_1 T2T-CHM13v2.0 6 130,076,331 - 130,710,229 (+) NCBI T2T-CHM13v2.0
Lama2 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 10 26,857,281 - 27,493,021 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 10 26,856,032 - 27,495,754 (-) Ensembl GRCm39 Ensembl GRCm38 10 26,981,285 - 27,617,191 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 10 26,980,036 - 27,619,758 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 10 26,701,091 - 27,336,748 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 10 26,670,819 - 27,306,267 (-) NCBI MGSCv36 mm8 Celera 10 27,907,208 - 28,541,586 (-) NCBI Celera Cytogenetic Map 10 A4 NCBI cM Map 10 14.23 NCBI
Lama2 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955436 9,830,030 - 10,399,891 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955436 9,829,777 - 10,400,101 (+) NCBI ChiLan1.0 ChiLan1.0
LAMA2 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 5 148,876,669 - 149,513,805 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 6 146,784,037 - 147,421,936 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 6 126,672,013 - 127,307,870 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 6 130,781,676 - 131,415,549 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 6 130,781,781 - 131,415,337 (+) Ensembl panpan1.1 panPan2
LAMA2 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 1 67,645,461 - 68,096,506 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 1 67,611,122 - 68,095,914 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 1 68,254,521 - 68,844,637 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 1 67,721,690 - 68,305,337 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 1 67,721,701 - 68,304,715 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 1 67,644,723 - 68,228,165 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 1 67,427,961 - 68,011,313 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 1 68,070,825 - 68,654,877 (+) NCBI UU_Cfam_GSD_1.0
Lama2
LAMA2 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 1 33,866,850 - 34,359,698 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 1 33,765,412 - 34,359,741 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 1 37,284,919 - 37,545,503 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
LAMA2 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 13 44,074,128 - 44,688,187 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 13 44,073,525 - 44,531,889 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666040 16,239,880 - 16,874,460 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Lama2
.
Predicted Target Of
Count of predictions: 115 Count of miRNA genes: 92 Interacting mature miRNAs: 95 Transcripts: ENSRNOT00000014917 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
631688 Hcas2 Hepatocarcinoma susceptibility QTL 2 3 0.0001 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 5925874 115540829 Rat 1578650 Bmd6 Bone mineral density QTL 6 12.2 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 1 509108 43284926 Rat 1354647 Despr8 Despair related QTL 8 0.0000341 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 1 1 24744506 Rat 1578651 Bmd7 Bone mineral density QTL 7 14.2 femur mineral mass (VT:0010011) compact volumetric bone mineral density (CMO:0001730) 1 509108 43284926 Rat 2313062 Bmd73 Bone mineral density QTL 73 3.9 0.0001 tibia mineral mass (VT:1000283) compact volumetric bone mineral density (CMO:0001730) 1 11481312 82174945 Rat 1554320 Bmd1 Bone mineral density QTL 1 12.2 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 1 509108 86060548 Rat 2313065 Bss67 Bone structure and strength QTL 67 3.1 0.0001 tibia area (VT:1000281) tibia total energy absorbed before break (CMO:0001736) 1 11481312 82174945 Rat 7421626 Bp360 Blood pressure QTL 360 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 4393289 49393289 Rat 2313070 Bss52 Bone structure and strength QTL 52 4.4 0.0001 body length (VT:0001256) body length (CMO:0000013) 1 1 32356093 Rat 2313069 Bss68 Bone structure and strength QTL 68 2.9 0.0001 tibia size trait (VT:0100001) tibia total energy absorbed before break (CMO:0001736) 1 11481312 82174945 Rat 631494 Bp95 Blood pressure QTL 95 40 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 16206210 49268520 Rat 2313075 Bss66 Bone structure and strength QTL 66 3.4 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 1 11481312 82174945 Rat 5684998 Bss101 Bone structure and strength QTL 101 3.6 tibia strength trait (VT:1000284) tibia ultimate force (CMO:0001734) 1 15431621 49361612 Rat 2298546 Neuinf4 Neuroinflammation QTL 4 5.1 nervous system integrity trait (VT:0010566) spinal cord RT1-B protein level (CMO:0002132) 1 1 28736750 Rat 5684999 Bss102 Bone structure and strength QTL 102 5.5 7e-07 tibia strength trait (VT:1000284) tibia stiffness (CMO:0001735) 1 15431621 49361612 Rat 1300167 Hrtrt2 Heart rate QTL 2 4.35 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 1 11481312 75088344 Rat 2313077 Bss69 Bone structure and strength QTL 69 3.5 0.0001 tibia strength trait (VT:1000284) bone polar moment of inertia (CMO:0001558) 1 11481312 82174945 Rat 2317755 Glom22 Glomerulus QTL 22 3.8 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 1 11481482 32355910 Rat 1578756 Iddm22 Insulin dependent diabetes mellitus QTL 22 2.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 11835181 56835181 Rat 631508 Sald1 Serum aldosterone level QTL 1 3.7 blood aldosterone amount (VT:0005346) serum aldosterone level (CMO:0000487) 1 9856001 54856001 Rat 2313090 Bmd69 Bone mineral density QTL 69 4.4 0.0001 tibia mineral mass (VT:1000283) compact volumetric bone mineral density (CMO:0001730) 1 1 32356093 Rat 4889451 Eae29 Experimental allergic encephalomyelitis QTL 29 5.51 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis severity score (CMO:0001419) 1 5925877 24697545 Rat 70179 Xhs2 X-ray hypersensitivity QTL 2 3.2 intestine integrity trait (VT:0010554) post-insult time to onset of moribundity (CMO:0001896) 1 15321100 19121980 Rat 2313092 Bmd72 Bone mineral density QTL 72 2.5 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 1 11481312 82174945 Rat 2313097 Bss70 Bone structure and strength QTL 70 3.5 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 1 11481312 82174945 Rat 738020 Pia8 Pristane induced arthritis QTL 8 4.7 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 1 1 65833076 Rat 1600360 Mcs16 Mammary carcinoma susceptibility QTL 16 2.4 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 1 2244390 43433040 Rat 1578669 Bss9 Bone structure and strength QTL 9 6.3 femur morphology trait (VT:0000559) bone trabecular cross-sectional area (CMO:0002311) 1 509108 43284926 Rat 2302038 Pia31 Pristane induced arthritis QTL 31 5.5 0.001 blood autoantibody amount (VT:0003725) serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111) 1 10992065 55992065 Rat 2313053 Bss51 Bone structure and strength QTL 51 3.8 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 1 1 32356093 Rat
D1Got23
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 18,212,061 - 18,212,241 (+) MAPPER mRatBN7.2 Rnor_6.0 1 19,034,627 - 19,034,806 NCBI Rnor6.0 Rnor_5.0 1 20,539,064 - 20,539,243 UniSTS Rnor5.0 RGSC_v3.4 1 18,776,338 - 18,776,518 RGD RGSC3.4 RGSC_v3.4 1 18,776,339 - 18,776,518 UniSTS RGSC3.4 RGSC_v3.1 1 18,776,401 - 18,776,580 RGD Celera 1 16,616,775 - 16,616,954 UniSTS RH 3.4 Map 1 179.2 UniSTS RH 3.4 Map 1 179.2 RGD RH 2.0 Map 1 105.5 RGD Cytogenetic Map 1 p12 UniSTS
RH129016
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 18,320,436 - 18,320,616 (+) MAPPER mRatBN7.2 Rnor_6.0 1 19,143,282 - 19,143,461 NCBI Rnor6.0 Rnor_5.0 1 20,647,052 - 20,647,231 UniSTS Rnor5.0 RGSC_v3.4 1 18,885,258 - 18,885,437 UniSTS RGSC3.4 Celera 1 16,723,914 - 16,724,093 UniSTS RH 3.4 Map 1 178.2 UniSTS Cytogenetic Map 1 p12 UniSTS
RH138034
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 17,910,359 - 17,910,570 (+) MAPPER mRatBN7.2 Rnor_6.0 1 18,730,287 - 18,730,497 NCBI Rnor6.0 Rnor_5.0 1 20,238,082 - 20,238,292 UniSTS Rnor5.0 RGSC_v3.4 1 18,442,358 - 18,442,568 UniSTS RGSC3.4 Celera 1 16,316,149 - 16,316,359 UniSTS RH 3.4 Map 1 178.3 UniSTS Cytogenetic Map 1 p12 UniSTS
EST-CFZ97756
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 17,718,112 - 17,718,464 (+) MAPPER mRatBN7.2 Rnor_6.0 1 18,535,680 - 18,536,031 NCBI Rnor6.0 Rnor_5.0 1 20,047,158 - 20,047,509 UniSTS Rnor5.0 RGSC_v3.4 1 18,249,000 - 18,249,351 UniSTS RGSC3.4 Celera 1 16,124,057 - 16,124,408 UniSTS Cytogenetic Map 1 p12 UniSTS
AU049510
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 1 19,690,444 - 19,690,731 (+) Marker Load Pipeline mRatBN7.2 1 17,870,999 - 17,871,286 (+) MAPPER mRatBN7.2 Rnor_6.0 1 18,690,967 - 18,691,253 NCBI Rnor6.0 Rnor_5.0 1 20,199,031 - 20,199,317 UniSTS Rnor5.0 RGSC_v3.4 1 18,402,537 - 18,402,823 UniSTS RGSC3.4 Celera 1 16,276,775 - 16,277,061 UniSTS Cytogenetic Map 1 p12 UniSTS
This gene Lama2 is modified in the following models/strains:
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000014917 ⟹ ENSRNOP00000014917
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 17,672,536 - 18,320,530 (+) Ensembl Rnor_6.0 Ensembl 1 18,491,384 - 19,143,269 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000079138 ⟹ ENSRNOP00000070049
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 17,672,714 - 18,320,530 (+) Ensembl Rnor_6.0 Ensembl 1 18,491,384 - 19,143,269 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000102071 ⟹ ENSRNOP00000078909
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 17,672,536 - 18,320,530 (+) Ensembl
RefSeq Acc Id:
NM_001427039 ⟹ NP_001413968
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 19,492,146 - 20,140,056 (+) NCBI
RefSeq Acc Id:
XM_063264627 ⟹ XP_063120697
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 19,492,126 - 20,140,056 (+) NCBI
RefSeq Acc Id:
XM_063264628 ⟹ XP_063120698
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 19,492,126 - 20,140,056 (+) NCBI
RefSeq Acc Id:
XM_063264629 ⟹ XP_063120699
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 19,492,126 - 20,140,056 (+) NCBI
RefSeq Acc Id:
XM_063264630 ⟹ XP_063120700
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 19,492,126 - 20,140,056 (+) NCBI
RefSeq Acc Id:
XM_063264632 ⟹ XP_063120702
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 19,492,126 - 20,140,056 (+) NCBI
RefSeq Acc Id:
XM_063264637 ⟹ XP_063120707
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 19,492,126 - 20,140,056 (+) NCBI
RefSeq Acc Id:
XM_063264642 ⟹ XP_063120712
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 19,492,126 - 20,140,056 (+) NCBI
Ensembl Acc Id:
ENSRNOP00000070049 ⟸ ENSRNOT00000079138
Ensembl Acc Id:
ENSRNOP00000014917 ⟸ ENSRNOT00000014917
Ensembl Acc Id:
ENSRNOP00000078909 ⟸ ENSRNOT00000102071
RefSeq Acc Id:
XP_063120697 ⟸ XM_063264627
- Peptide Label:
isoform X1
- UniProtKB:
F1M614 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063120698 ⟸ XM_063264628
- Peptide Label:
isoform X2
- UniProtKB:
F1M614 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063120700 ⟸ XM_063264630
- Peptide Label:
isoform X4
- UniProtKB:
F1M614 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063120702 ⟸ XM_063264632
- Peptide Label:
isoform X5
- UniProtKB:
A0A8I5ZPP7 (UniProtKB/TrEMBL), F1M614 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063120699 ⟸ XM_063264629
- Peptide Label:
isoform X3
- UniProtKB:
F1M614 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063120707 ⟸ XM_063264637
- Peptide Label:
isoform X6
- UniProtKB:
F1M614 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063120712 ⟸ XM_063264642
- Peptide Label:
isoform X7
- UniProtKB:
A6JPF2 (UniProtKB/TrEMBL), F1M614 (UniProtKB/TrEMBL)
RefSeq Acc Id:
NP_001413968 ⟸ NM_001427039
- Peptide Label:
precursor
- UniProtKB:
A0A0G2JWX2 (UniProtKB/TrEMBL), F1M614 (UniProtKB/TrEMBL)
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-04-30
Lama2
laminin, alpha 2
Lama2_predicted
laminin, alpha 2 (predicted)
'predicted' is removed
2292626 APPROVED
2005-01-12
Lama2_predicted
laminin, alpha 2 (predicted)
Symbol and Name status set to approved
70820 APPROVED
